NasdaqGS - Delayed Quote USD

Halozyme Therapeutics, Inc. (HALO)

38.57 +0.11 (+0.29%)
At close: April 26 at 4:00 PM EDT
37.13 -1.44 (-3.73%)
After hours: April 26 at 7:49 PM EDT

Insider Roster

Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.

Individual or EntityMost Recent TransactionDateShares Owned as of Transaction Date
BIZZARI JEAN-PIERRE Director Stock Award(Grant) May 5, 2023 66,815
DALY JAMES M. Director Sale Aug 14, 2023 20,503
DUNCAN BARBARA GAYLE Director Stock Award(Grant) May 5, 2023 9,253
HENDERSON JEFFREY WILLIAM Director Stock Award(Grant) May 5, 2023 47,110
LABARRE MICHAEL J. Chief Technology Officer Sale Apr 17, 2024 168,176
LABROSSE NICOLE Chief Financial Officer Conversion of Exercise of derivative security Feb 16, 2024 15,480
MATSUI CONNIE L Director Stock Award(Grant) May 5, 2023 187,004
POSARD MATTHEW L Director Stock Award(Grant) May 5, 2023 113,254
SNYDER MARK HOWARD General Counsel Conversion of Exercise of derivative security Feb 16, 2024 11,680
TORLEY HELEN I Chief Executive Officer Conversion of Exercise of derivative security Feb 16, 2024 676,744

Related Tickers